This trader will be eyeing The Trade Desk and QQQ to figure out what to do next.
Bullish divergences may finally generate a bounce, Here's how to trade it.
Let's take a technical follow-up look at MDB -- and give a word of caution on this software name.
Let's review the charts and indicators.
Folks are asking if it's finally time to buy the ARK Innovation exchange-traded fund or Apple. Let's check the charts.
Someone already long this stock, who has taken a hit, doesn't need to liquidate unless...
The technical signs indicate that the stock of the data analytics company still needs to build a base.
The liquidity that pushed up all risky assets is now the leading factor in taking them down.
Let's see how the charts look before earnings Wednesday night.
Shares of medical network platform Doximity are positioned for a rally, according to the charts.
It appears that hedge fund owner Michael Burry is betting against AAPL and Warren Buffett is betting on the stock. But let's look at their strategies and why they might both turn out winners.
Similar to biotech, the small adtech space has been hammered in recent quarters and has likely hit oversold territory.
In a blow to the bulls, AAPL and MSFT surrender to the inevitable, as Chief Powell aims a bazooka at inflation.
Here's what has us worried -- and how low the stock could go.
Cathie Wood's ARK Innovation ETF and its constituent stocks bounced on Thursday, though they collectively remain deep in bear market territory.
The Kospi has shown dramatic volatility in the last year, but Seoul stocks now look undervalued, particularly those in in-demand sectors.
As the Fed tries to steer the smoking U.S. economy into a soft landing, many funds have been reduced to cyber rubble. But we can find some working -- or workable -- parts amid the rust and embers.
But is this stock that's soaring on Thursday more than a quick flip with forming a base? Let's check the charts.
With no bottom in sight, traders and investors should avoid the long side of the online gaming platform.
There's no way around it, Coinbase's charts look tarnished following its earnings miss. Let's see if there's a silver lining in this for traders ... or not.
For now, any rebound is a short-term trading opportunity and nothing more.
We see some interesting clues as we examine MHCP's charts.
Here's why I just can't recommend this former Cathie Wood pick right now.
Following their recent selloffs, two of these major chip developers arguably present compelling risk/rewards.
Rather than try to catch falling knives, traders should give a look at Merck, IBM and Procter & Gamble.
Plus, we take a revealing look at the movements in the yield curve and pop in on the dismal charts of Shopify and Peloton Interactive.
The Fed officially embarking on a rate hike campaign should have investors reassessing the composition of their portfolios to adjust for risk.
Follow Real Money's Wall Street Pros to receive real-time investing alerts
Already a Subscriber? Login